FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third ...
Tag: Eli
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
Alphabet taps Eli Lilly’s Anat Ashkenazi as new CFO
A view of Google Headquarters in Mountain View, California, United States on April 16, 2024. Tayfun Coskun | Anadolu | Getty ...
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Mike Blake ...
Eli Lilly teams with Amazon to offer home delivery of its Zepbound weight-loss drug
Four months after Eli Lilly obtained regulatory approval to sell its diabetes medication under a different name for weight loss, ...
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado ...
Eli Lilly’s new ad says weight-loss drugs shouldn’t be used out of “vanity”
Eli Lilly has a message for people who are taking prescription medications developed for patients with Type 2 diabetes and ...
The U.S. Food and Drug Administration approves Eli Lilly’s Zepbound drug for weight loss
The U.S. Food and Drug Administration approves Eli Lilly's Zepbound drug for weight loss - CBS News
FDA approves a new weight loss drug, Zepbound from Eli Lilly
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which ...
